Taliglucerase alfa
Drug Details
- Generic Name
- Taliglucerase alfa
- Brand Names
- ELELYSO
- Application Number
- BLA022458
- Sponsor
- Protalix Ltd
- NDC Codes
- 4
- Dosage Forms
- LIQUID, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, INJECTION, POWDER, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- TALIGLUCERASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE ELELYSO is indicated for the treatment of patients 4 years of age and older with a confirmed diagnosis of Type 1 Gaucher disease. ELELYSO is a hydrolytic lysosomal glucocerebroside-specific enzyme indicated for the treatment of patients 4 years and older with a confirmed diagnosis of Type 1 Gaucher disease ( 1 ).